PMGC Holdings Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ELAB research report →
About the company
PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists.
- CEO
- Graydon Bensler
- IPO
- 2023
- Employees
- 2
- HQ
- Newport Beach, CA, US
Price Chart
- Market Cap
- $2.29M
- P/E
- -0.01
- P/S
- 1.80
- P/B
- 0.04
- EV/EBITDA
- 0.46
- Div Yield
- 0.00%
- Gross Margin
- 12.68%
- Op Margin
- -746.57%
- Net Margin
- -873.11%
- ROE
- -116.96%
- ROIC
- -46.11%
- Revenue
- $590.08K · -76.08%
- Net Income
- $-7,708,137 · -23.41%
- EPS
- $-378.74 · 94.25%
- Op Income
- $-7,376,710
- FCF YoY
- -16.31%
- 52W High
- $309.89
- 52W Low
- $1.06
- 50D MA
- $1.81
- 200D MA
- $49.98
- Beta
- -0.24
- Avg Volume
- 4.38M
Get TickerSpark's AI analysis on ELAB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 1, 26 | Parry Jeffrey | other | 75,046 |
| Jun 1, 26 | Kovalyov George | other | 75,046 |
| Jun 1, 26 | Daley Juliana | other | 75,046 |
| Jun 1, 26 | Braeden Lichti | other | 450,277 |
| Nov 13, 23 | Parry Jeffrey | other | 0 |
| Sep 30, 22 | Parry Jeffrey | other | 1 |
| Sep 30, 22 | Parry Jeffrey | other | 4 |
| Nov 13, 23 | Daley Juliana | other | 0 |
| Jun 1, 23 | Daley Juliana | other | 4 |
| Mar 6, 24 | Kovalyov George | other | 0 |
Our ELAB coverage
Recent articles, reports, and earnings notes.
No research on ELAB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ELAB report →Similar companies
Peers in the same neighborhood.